Helicobacter pylori infection induced gastric cancer; Advance in gastric stem cell research and the remaining challenges

Gut Pathogens

Volumn 4, Issue 1, 2012, Pages

  Ding, Song Ze ^a,b   Zheng, Peng Yuan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cancer; Epigenetics; Gastric epithelial cells; Helicobacter pylori (H. pylori); Stem cell

Indexed keywords

EID: 84871859339     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-4-18     Document Type: Review

References (60)

1. Helicobacter infection and gastric neoplasia. Peek RM Jr, Crabtree JE, J Pathol 2006 208 233 248 10.1002/path.1868 16362989 (Pubitemid 43126116)
2. The translation of Helicobacter pylori basic research to patient care. Ernst PB, Peura DA, Crowe SE, Gastroenterology 2006 130 188 206 quiz 212-3 10.1053/j.gastro.2005.06.032 16401482 (Pubitemid 43049849)
3. Gastric cancer originating from bone marrow-derived cells. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC, Science 2004 306 1568 1571 10.1126/science.1099513 15567866 (Pubitemid 39564955)
4. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS, Proc Natl Acad Sci U S A 1999 96 14559 14564 10.1073/pnas.96.25.14559 10588744 (Pubitemid 30000689)
5. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL, Nat Immunol 2004 5 1166 1174 10.1038/ni1131 15489856 (Pubitemid 39549631)
6. Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Hatakeyama M, Oncogene 2008 27 7047 7054 10.1038/onc.2008.353 19029944
7. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Radin JN, Gonzalez-Rivera C, Ivie SE, McClain MS, Cover TL, Infect Immun 2011 79 2535 2543 10.1128/IAI.01370-10 21482684
8. Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Odenbreit S, Swoboda K, Barwig I, Ruhl S, Boren T, Koletzko S, Haas R, Infect Immun 2009 77 3782 3790 10.1128/IAI.00364-09 19546190
9. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Ding SZ, Goldberg JB, Hatakeyama M, Future Oncol 2010 6 851 862 10.2217/fon.10.37 20465395
10. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr, Azuma T, Hatakeyama M, Oncogene 2007 26 4617 4626 10.1038/sj.onc.1210251 17237808 (Pubitemid 47067401)
11. Activation of beta-catenin by carcinogenic Helicobacter pylori. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O'Brien DP, Romero-Gallo J, Peek RM Jr, Proc Natl Acad Sci U S A 2005 102 10646 10651 10.1073/pnas.0504927102 16027366 (Pubitemid 41061608)
12. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG, Gastroenterology 2000 118 36 47 10.1016/S0016-5085(00)70412-4 10611152 (Pubitemid 30020371)
13. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M, Gastroenterology 2006 131 1086 1095 10.1053/j.gastro.2006.07.014 17030179 (Pubitemid 44498691)
14. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, Yamada G, Azuma T, Hatakeyama M, Proc Natl Acad Sci U S A 2008 105 1003 1008 10.1073/pnas.0711183105 18192401 (Pubitemid 351282071)
15. beta-Catenin and p120 mediate PPARdelta-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Nagy TA, Wroblewski LE, Wang D, Piazuelo MB, Delgado A, Romero-Gallo J, Noto J, Israel DA, Ogden SR, Correa P, Cover TL, Peek RM Jr, Gastroenterology 2011 141 553 564 10.1053/j.gastro.2011.05.004 21704622
16. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, Oshima M, EMBO J 2008 27 1671 1681 10.1038/emboj.2008.105 18511911
17. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC, Cancer Cell 2008 14 408 419 10.1016/j.ccr.2008.10. 011 18977329
18. IFN-gamma inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Tu SP, Quante M, Bhagat G, Takaishi S, Cui G, Yang XD, Muthuplani S, Shibata W, Fox JG, Pritchard DM, Wang TC, Cancer Res 2011 71 4247 4259 10.1158/0008-5472.CAN-10-4009 21512143
19. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS, Nature 2000 404 398 402 10.1038/35006081 10746728 (Pubitemid 30164342)
20. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Peterson AJ, Menheniott TR, O'Connor L, Walduck AK, Fox JG, Kawakami K, Minamoto T, Ong EK, Wang TC, Judd LM, Giraud AS, Gastroenterology 2010 139 2005 2017 10.1053/j.gastro.2010.08.043 20801119
21. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Tomita H, Takaishi S, Menheniott TR, Yang X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C, Rio MC, Lerkowit N, Varro A, Giraud AS, Wang TC, Gastroenterology 2011 140 879 891 10.1053/j.gastro.2010.11.037 21111741
22. Cellular origin of gastric cancer. Karam SM, Ann N Y Acad Sci 2008 1138 162 168 10.1196/annals.1414.023 18837897
23. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, Clevers H, Cell Stem Cell 2010 6 25 36 10.1016/j.stem.2009.11.013 20085740
24. Prospective identification of a multilineage progenitor in murine stomach epithelium. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL, Gastroenterology 2007 133 1989 1998 10.1053/j.gastro.2007.09.031 18054570 (Pubitemid 350180818)
25. The Spatial Distribution of LGR5(+) Cells Correlates With Gastric Cancer Progression. Simon E, Petke D, Boger C, Behrens HM, Warneke V, Ebert M, Rocken C, PLoS One 2012 7 35486 10.1371/journal.pone.0035486 22530031
26. H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Uehara T, Ma D, Yao Y, Lynch JP, Morales K, Ziober A, Feldman M, Ota H, Sepulveda AR, Dig Dis Sci 2012 Sept Epub ahead of print
27. TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. Quante M, Marrache F, Goldenring JR, Wang TC, Gastroenterology 2010 139 2018 2027 e2 10.1053/j.gastro.2010.08.003 20708616
28. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist. Goldenring JR, Nam KT, Mills JC, Exp Cell Res 2011 317 2759 2764 10.1016/j.yexcr.2011.08.017 21907708
29. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM Jr, Konieczny SF, Goldenring JR, Gastroenterology 2010 139 2028 2037 e9 10.1053/j.gastro.2010.09.005 20854822
30. The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer. Jang BI, Li Y, Graham DY, Cen P, Gut Liver 2011 5 397 405 10.5009/gnl.2011.5.4.397 22195236
31. Prospective identification of tumorigenic breast cancer cells. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, Proc Natl Acad Sci U S A 2003 100 3983 3988 10.1073/pnas.0530291100 12629218 (Pubitemid 36418143)
32. Identification of gastric cancer stem cells using the cell surface marker CD44. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC, Stem Cells 2009 27 1006 1020 10.1002/stem.30 19415765
33. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A, Liguori E, Pirozzi G, Tirino V, Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP, Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G, Nardone G, J Cell Physiol 2012 227 2686 2693 10.1002/jcp.23013 21898409
34. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. Liu YJ, Yan PS, Li J, Jia JF, World J Gastroenterol 2005 11 6601 6606 16425351 (Pubitemid 43072697)
35. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z, Oncogene 2012 31 671 682 10.1038/onc.2011.282 21743497
36. Significance of CD90+ cancer stem cells in human liver cancer. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST, Cancer Cell 2008 13 153 166 10.1016/j.ccr.2008.01.013 18242515 (Pubitemid 351163165)
37. Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors. Oikonomou D, Hassan K, Kaifi JT, Fiegel HC, Schurr PG, Reichelt U, Aridome K, Yekebas EF, Mann O, Kluth D, Strate T, Izbicki JR, J Cancer Res Clin Oncol 2007 133 951 955 10.1007/s00432-007-0238-5 17534660 (Pubitemid 47561711)
38. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation. Fukamachi H, Shimada S, Ito K, Ito Y, Yuasa Y, Cancer Sci 2011 102 1313 1321 10.1111/j.1349-7006.2011.01947.x 21457403
39. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, Clevers H, Gastroenterology 2009 136 2187 2194 e1 10.1053/j.gastro.2009.03. 002 19324043
40. Sequential expression of putative stem cell markers in gastric carcinogenesis. Wang T, Ong CW, Shi J, Srivastava S, Yan B, Cheng CL, Yong WP, Chan SL, Yeoh KG, Iacopetta B, Salto-Tellez M, Br J Cancer 2011 105 658 665 10.1038/bjc.2011.287 21829201
41. Expression of a candidate marker for progenitor cells, Musashi-1, in the proliferative regions of human antrum and its decreased expression in intestinal metaplasia. Akasaka Y, Saikawa Y, Fujita K, Kubota T, Ishikawa Y, Fujimoto A, Ishii T, Okano H, Kitajima M, Histopathology 2005 47 348 356 10.1111/j.1365-2559.2005.02223.x 16178889 (Pubitemid 41428483)
42. Helicobacter pylori infection induces candidate stem cell marker Musashi-1 in the human gastric epithelium. Murata H, Tsuji S, Tsujii M, Nakamura T, Fu HY, Eguchi H, Asahi K, Okano H, Kawano S, Hayashi N, Dig Dis Sci 2008 53 363 369 10.1007/s10620-007-9858-5 17549630 (Pubitemid 351170002)
43. The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis. Fukui T, Kishimoto M, Nakajima A, Yamashina M, Nakayama S, Kusuda T, Sakaguchi Y, Yoshida K, Uchida K, Nishio A, Matsuzaki K, Okazaki K, J Gastroenterol 2011 46 456 468 10.1007/s00535-010-0364-8 21229365
44. DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. Gerbe F, Brulin B, Makrini L, Legraverend C, Jay P, Gastroenterology 2009 137 2179 2180 author reply 2180-1 10.1053/j.gastro.2009.06.072 19879217
45. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. Schmuck R, Warneke V, Behrens HM, Simon E, Weichert W, Rocken C, Am J Pathol 2011 178 1792 1804 10.1016/j.ajpath.2010.12.043 21435459
46. Cross-talk between aging and cancer: the epigenetic language. Fraga MF, Agrelo R, Esteller M, Ann N Y Acad Sci 2007 1100 60 74 10.1196/annals.1395.005 17460165 (Pubitemid 47092639)
47. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Necchi V, Candusso ME, Tava F, Luinetti O, Ventura U, Fiocca R, Ricci V, Solcia E, Gastroenterology 2007 132 1009 1023 10.1053/j.gastro.2007.01.049 17383424 (Pubitemid 46440875)
48. Intracellular Helicobacter pylori in gastric epithelial progenitors. Oh JD, Karam SM, Gordon JI, Proc Natl Acad Sci U S A 2005 102 5186 5191 10.1073/pnas.0407657102 15795379
49. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI, Proc Natl Acad Sci U S A 2008 105 4358 4363 10.1073/pnas.0800668105 18332421 (Pubitemid 351754385)
50. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Varon C, Dubus P, Mazurier F, Asencio C, Chambonnier L, Ferrand J, Giese A, Senant-Dugot N, Carlotti M, Megraud F, Gastroenterology 2012 142 281 291 10.1053/j.gastro.2011.10.036 22062361
51. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, Ichinose M, Tatematsu M, Ushijima T, Cancer Res 2010 70 1430 1440 10.1158/0008-5472.CAN-09-2755 20124475
52. The tumor microenvironment and its role in promoting tumor growth. Whiteside TL, Oncogene 2008 27 5904 5912 10.1038/onc.2008.271 18836471
53. The cancer stem cell niche-there goes the neighborhood? Cabarcas SM, Mathews LA, Farrar WL, Int J Cancer 2011 129 2315 2327 10.1002/ijc.26312 21792897
54. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS, PLoS Biol 2009 7 1000121 10.1371/journal. pbio.1000121 19492080
55. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS, Cancer Res 2006 66 6063 6071 10.1158/0008-5472. CAN-06-0054 16778178
56. An epigenetic switch involving NF-kappaB, Lin28, Let-7 Micro RNA, and IL6 links inflammation to cell transformation. Iliopoulos D, Hirsch HA, Struhl K, Cell 2009 139 693 706 10.1016/j.cell.2009.10.014 19878981
57. Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium. Okumura T, Wang SS, Takaishi S, Tu SP, Ng V, Ericksen RE, Rustgi AK, Wang TC, Lab Invest 2009 89 12 1410 1422 10.1038/labinvest.2009.88 19841619
58. Chronic inflammation, the tumor microenvironment and carcinogenesis. Gonda TA, Tu S, Wang TC, Cell Cycle 2009 8 2005 2013 10.4161/cc.8.13.8985 19550141
59. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. Ferrand J, Lehours P, Schmid-Alliana A, Megraud F, Varon C, PLoS One 2011 6 29007 10.1371/journal.pone.0029007 22216156
60. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Grivennikov SI, Karin M, Cytokine Growth Factor Rev 2010 21 11 19 10.1016/j.cytogfr.2009.11.005 20018552